Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
Jian-Xian LinJun-Peng LinJian-Wei XieJia-Bin WangJun LuQi-Yue ChenLong-Long CaoMi LinRuhong TuChao-Hui ZhengChang-Ming HuangPing LiPublished in: BMC cancer (2020)
The preoperative LMR and Hb level were optimal CBC-based biomarkers for predicting OS in GC patients after curative resection. Based on the LMR and Hb, we developed a novel and easily obtainable prognostic score called the CBCS, which may improve the prediction of clinical outcomes.